SE336429B - - Google Patents
Info
- Publication number
- SE336429B SE336429B SE08631/66A SE863166A SE336429B SE 336429 B SE336429 B SE 336429B SE 08631/66 A SE08631/66 A SE 08631/66A SE 863166 A SE863166 A SE 863166A SE 336429 B SE336429 B SE 336429B
- Authority
- SE
- Sweden
- Prior art keywords
- aluminium
- carbonate
- magnesium
- phosphate
- bismuth
- Prior art date
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 3
- 229910018626 Al(OH) Inorganic materials 0.000 abstract 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 239000004411 aluminium Substances 0.000 abstract 2
- 229910052782 aluminium Inorganic materials 0.000 abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 2
- 235000012211 aluminium silicate Nutrition 0.000 abstract 2
- 229940069428 antacid Drugs 0.000 abstract 2
- 239000003159 antacid agent Substances 0.000 abstract 2
- 239000005995 Aluminium silicate Substances 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 abstract 1
- 239000004382 Amylase Substances 0.000 abstract 1
- 102000013142 Amylases Human genes 0.000 abstract 1
- 108010065511 Amylases Proteins 0.000 abstract 1
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 abstract 1
- 108010059892 Cellulase Proteins 0.000 abstract 1
- 239000001692 EU approved anti-caking agent Substances 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000009338 Gastric Mucins Human genes 0.000 abstract 1
- 108010009066 Gastric Mucins Proteins 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- PQMWYJDJHJQZDE-UHFFFAOYSA-M Methantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 PQMWYJDJHJQZDE-UHFFFAOYSA-M 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 239000003463 adsorbent Substances 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- -1 aluminium monocarbonate hexitol complexes Chemical class 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 229910000323 aluminium silicate Inorganic materials 0.000 abstract 1
- 235000019418 amylase Nutrition 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 239000000440 bentonite Substances 0.000 abstract 1
- 229910000278 bentonite Inorganic materials 0.000 abstract 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract 1
- 229940104825 bismuth aluminate Drugs 0.000 abstract 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 abstract 1
- 229940036358 bismuth subcarbonate Drugs 0.000 abstract 1
- JAONZGLTYYUPCT-UHFFFAOYSA-K bismuth subgallate Chemical compound OC(=O)C1=CC(O)=C2O[Bi](O)OC2=C1 JAONZGLTYYUPCT-UHFFFAOYSA-K 0.000 abstract 1
- 229960000199 bismuth subgallate Drugs 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 235000010216 calcium carbonate Nutrition 0.000 abstract 1
- 108010033929 calcium caseinate Proteins 0.000 abstract 1
- 229940106157 cellulase Drugs 0.000 abstract 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 abstract 1
- CRPOUZQWHJYTMS-UHFFFAOYSA-N dialuminum;magnesium;disilicate Chemical compound [Mg+2].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] CRPOUZQWHJYTMS-UHFFFAOYSA-N 0.000 abstract 1
- PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical compound [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 abstract 1
- 102000038379 digestive enzymes Human genes 0.000 abstract 1
- 108091007734 digestive enzymes Proteins 0.000 abstract 1
- 239000003974 emollient agent Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 229910001679 gibbsite Inorganic materials 0.000 abstract 1
- PDSAKIXGSONUIX-UHFFFAOYSA-N hexaaluminum;dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Bi+3].[Bi+3] PDSAKIXGSONUIX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 abstract 1
- 235000012243 magnesium silicates Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052901 montmorillonite Inorganic materials 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 1
- 235000019731 tricalcium phosphate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US467684A US3329564A (en) | 1965-06-28 | 1965-06-28 | Antacid preparations and means of producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE336429B true SE336429B (en:Method) | 1971-07-05 |
Family
ID=23856701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE08631/66A SE336429B (en:Method) | 1965-06-28 | 1966-06-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3329564A (en:Method) |
| BE (1) | BE683138A (en:Method) |
| BR (1) | BR6680739D0 (en:Method) |
| FR (1) | FR6012M (en:Method) |
| GB (1) | GB1078879A (en:Method) |
| SE (1) | SE336429B (en:Method) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5663915A (en) * | 1979-10-27 | 1981-05-30 | Lion Corp | Tooth paste composition |
| US4551431A (en) * | 1983-04-21 | 1985-11-05 | Phillips Petroleum Company | The use of gallium and indium salts for the immobilization of proteins |
| DE4424675A1 (de) * | 1994-07-13 | 1996-01-18 | Bayer Ag | Antacidazubereitung mit verbessertem Sicherheitsprofil |
| US5498426A (en) * | 1994-10-03 | 1996-03-12 | The Procter & Gamble Company | Liquid antacid compositions |
| HK1041219B (en) | 1999-02-05 | 2011-10-21 | 爱尔开-阿贝优公司 | Mucosal delivery system |
| DK2116257T3 (da) * | 2000-08-09 | 2013-02-04 | Alk Abello As | Parenterale vaccineformuleringer og anvendelser deraf |
| US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
| US20100092550A1 (en) * | 2008-10-14 | 2010-04-15 | Nelson Cabral | Alka-eeze |
-
1965
- 1965-06-28 US US467684A patent/US3329564A/en not_active Expired - Lifetime
-
1966
- 1966-06-23 SE SE08631/66A patent/SE336429B/xx unknown
- 1966-06-24 BR BR180739/66A patent/BR6680739D0/pt unknown
- 1966-06-24 GB GB28535/66A patent/GB1078879A/en not_active Expired
- 1966-06-24 BE BE683138D patent/BE683138A/xx unknown
- 1966-09-23 FR FR66907A patent/FR6012M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE683138A (en:Method) | 1966-12-01 |
| GB1078879A (en) | 1967-08-09 |
| US3329564A (en) | 1967-07-04 |
| FR6012M (en:Method) | 1968-05-06 |
| BR6680739D0 (pt) | 1973-12-26 |
| DE1617726A1 (de) | 1971-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE336429B (en:Method) | ||
| AU455177B2 (en) | Improvements relating to hospital beds | |
| ES420483A1 (es) | Un procedimiento para la sintesis de un silicato de magne- sio hidratado. | |
| IE37639L (en) | Manufacture of magnesium alumino silicate | |
| CA925654A (en) | Invalid bed construction | |
| GB1098980A (en) | Novel medicines for the treatment of peptic ulcers | |
| GB1311653A (en) | Clay | |
| ATE20229T1 (de) | Pharmazeutisch wirksame organische germaniumverbindungen. | |
| AU456659B2 (en) | Clear liquid laxative antacid composition | |
| GB1363725A (en) | Calcium magnesium silicate hydrates | |
| GB1115370A (en) | Compositions of matter containing complex cariostatic agents | |
| FR2123632A6 (en) | Prepn of 5-azacytosines and 5-azacytidines - from bis trimethylsilyl-5-azacytosine | |
| GB973829A (en) | Improvements in or relating to silicate grouts | |
| Hilmy et al. | Gas Cysts of the 3ejunum.[Pneumatosis cystoides intestinalis]: report of a case | |
| AU468547B2 (en) | Stabilised silicic acid solutions and their use as binding agents | |
| GB1056212A (en) | Improved antacid composition and method for preparing the same | |
| GB1076904A (en) | Silicates | |
| AU451481B2 (en) | VENTILATOR STRUCTURE Additional to 434, 607) | |
| GB1253008A (en:Method) | ||
| GB1134097A (en) | Improvements in antacid tablets | |
| JPS55136118A (en) | Manufacture of aluminum silicate type adsorbent | |
| GB1242830A (en) | USE OF PENTACALCIUM ORTHOPERIODATE, Ca5(IO6)2, IN A SALT BLOCK AND FEEDS | |
| GB1025431A (en) | Neomycin salt | |
| LEE | The Effect of H2-receptor in the Treatment of Peptic Ulcer | |
| CA860912A (en) | Codried aluminum hydroxide-aluminum chelate antacid |